The HPAP team is happy to announce the publication of our newest study and resource. Here, we perform single base resolution DNA methylation analysis of human alpha, beta and exocrine cells to map epigenomic transitions in aging and T2D. https://t.co/rdYxBAX77U
We are happy to report that HPAP processed 5 new cases in the last 5 days - thanks so much to the tremendous efforts of our procurement team in these difficult times!
HPAP is proud to announce the publication of its new findings on a lymphotoxin beta signature in the lymph nodes and pancreas of people with T1D. https://t.co/1TXAreiFT2
Funding Opportunity
Emerging Leader Initiative aimed at providing support and protected time for senior Postdocs seeking to pursue studies that will enhance their transition toward independent research careers.
Due May 1st
Learn more at: https://t.co/RsjS9MnWFS
Please share!
Didn’t get the grad school interview you wanted yet? Turn this year into a launchpad. The Vahedi Lab @Penn is hiring a Research Specialist A/B — ideal for undergrads & recent grads aiming for PhD/MD-PhD programs.🧬 Immunology + genomics. Apply here: https://t.co/UwqT3zpkvH
We are grateful that our paper https://t.co/k2uM9DmCMv in @SciImmunology is featured at Penn Today; thanks to @bfariabi@TheHPAP and all collaborators https://t.co/ndtLRka5mV
A study co-led by @golnaz_v, @PennGenetics, finds new clues in pancreatic lymph nodes and the spleen that could help detect—and even stop—Type 1 diabetes. @SciImmunology https://t.co/TmCk0qCyib
In this article, I share my perspective on leveraging AI and single-cell profiling to predict type 1 diabetes. It’s great to see the diverse insights contributed by other experts in the field: https://t.co/DGwLuxiNIc
New research published in Nature Communications with UFDI collaborators Dr. Melanie Shapiro, Dr. Mark Atkinson, and Dr. Todd Brusko reveals immune cell disruptions in pancreatic lymphatic tissues may precede Type 1 Diabetes onset—offering key insights into early detection and intervention. Click here to read more https://t.co/9GNiTdkYb6
@Mel_Shapiro_PhD@matkinsonT1D@Bruskolab@UFMedicine@UFHealth@NatureComms
🚨New work from our lab with important clinical implications. Thanks to our collaborators in @TheHPAP. Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetes | bioRxiv https://t.co/imwnhepWdx
Two new, NIH funded postdoc positions are available! (1) Somatic mutations as primary causes of autoimmune disease and (2) Epigenetic drivers of diabetes in humans - please send CV and names of references to: [email protected]
In the new series by Diabetes Care highlighting 75 years of NIH NIDDK research, the groundbreaking TEDDY Study is featured. This pioneering study is helping better understand the environmental determinants of Type 1 Diabetes in youth and includes UFDI faculty investigators — Dr. Desmond Schatz, Dr. Michael Haller and Dr. Eric Triplett. Click here to read more: https://t.co/qFAMjJdHMw @AmDiabetesAssn@UFPedEndo@UFHealth@HallerMichael@ewtriplett #T1D #diabetes